Detailed information for compound 1027171

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 333.314 | Formula: C16H16FN3O4
  • H donors: 0 H acceptors: 4 LogP: 3.02 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC(Cn1c(C)ncc1[N+](=O)[O-])OC(=O)/C=C/c1ccccc1F
  • InChi: 1S/C16H16FN3O4/c1-11(10-19-12(2)18-9-15(19)20(22)23)24-16(21)8-7-13-5-3-4-6-14(13)17/h3-9,11H,10H2,1-2H3/b8-7+
  • InChiKey: XNXBNVOROGEMRP-BQYQJAHWSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Escherichia coli 3-oxoacyl-[acyl-carrier-protein] synthase III Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Plasmodium knowlesi beta-ketoacyl-acyl carrier protein synthase III precursor, putative Get druggable targets OG5_129509 All targets in OG5_129509
Mycobacterium ulcerans 3-oxoacyl-ACP synthase Get druggable targets OG5_129509 All targets in OG5_129509
Mycobacterium tuberculosis 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) Get druggable targets OG5_129509 All targets in OG5_129509
Mycobacterium ulcerans 3-oxoacyl-ACP synthase Get druggable targets OG5_129509 All targets in OG5_129509
Wolbachia endosymbiont of Brugia malayi 3-oxoacyl-ACP synthase Get druggable targets OG5_129509 All targets in OG5_129509
Neospora caninum 3-oxoacyl-(acyl-carrier-protein) synthase III family protein, putative Get druggable targets OG5_129509 All targets in OG5_129509
Plasmodium berghei apicoplast beta-ketoacyl-acyl carrier protein synthase III precursor, putative Get druggable targets OG5_129509 All targets in OG5_129509
Plasmodium falciparum beta-ketoacyl-ACP synthase III Get druggable targets OG5_129509 All targets in OG5_129509
Chlamydia trachomatis oxoacyl-ACP synthase III Get druggable targets OG5_129509 All targets in OG5_129509
Plasmodium vivax beta-ketoacyl-acyl carrier protein synthase III precursor, putative Get druggable targets OG5_129509 All targets in OG5_129509
Mycobacterium ulcerans beta-ketoacyl synthase-like protein Get druggable targets OG5_129509 All targets in OG5_129509

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Mycobacterium tuberculosis Conserved hypothetical protein 3-oxoacyl-[acyl-carrier-protein] synthase III 317 aa 265 aa 26.0 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma cruzi PAB1-binding protein , putative 0.0024 0.0536 0.5
Loa Loa (eye worm) hypothetical protein 0.0012 0.0212 0.0911
Loa Loa (eye worm) intermediate filament tail domain-containing protein 0.0026 0.0581 0.4713
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0062 0.5
Entamoeba histolytica fatty acid elongase, putative 0.005 0.1205 0.5
Brugia malayi CXXC zinc finger family protein 0.0028 0.0641 0.5338
Brugia malayi intermediate filament protein 0.0026 0.0581 0.4729
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0062 0.5
Trypanosoma brucei PAB1-binding protein , putative 0.0024 0.0536 0.5
Wolbachia endosymbiont of Brugia malayi 3-oxoacyl-ACP synthase 0.0383 1 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0062 0.5
Schistosoma mansoni mixed-lineage leukemia protein mll 0.0007 0.0079 0.0531
Onchocerca volvulus 0.0028 0.0641 1
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0062 0.5
Brugia malayi hypothetical protein 0.0024 0.0536 0.4267
Entamoeba histolytica fatty acid elongase, putative 0.005 0.1205 0.5
Schistosoma mansoni cpg binding protein 0.003 0.0683 0.4619
Brugia malayi hypothetical protein 0.0016 0.0308 0.1923
Echinococcus multilocularis musashi 0.0026 0.0581 0.495
Echinococcus multilocularis Ataxin 2, N terminal,domain containing protein 0.0011 0.0181 0.1013
Loa Loa (eye worm) intermediate filament protein 0.0026 0.0581 0.4713
Trichomonas vaginalis chromodomain-helicase-DNA-binding protein, putative 0.0006 0.0062 0.5
Entamoeba histolytica fatty acid elongase, putative 0.005 0.1205 0.5
Brugia malayi Intermediate filament tail domain containing protein 0.0026 0.0581 0.4729
Loa Loa (eye worm) hypothetical protein 0.0024 0.0536 0.4249
Trichomonas vaginalis helicase, putative 0.0006 0.0062 0.5
Echinococcus granulosus histone lysine N methyltransferase MLL3 0.0009 0.0124 0.0449
Echinococcus granulosus cytoplasmic intermediate filament protein 0.0013 0.0225 0.1443
Entamoeba histolytica fatty acid elongase, putative 0.005 0.1205 0.5
Leishmania major hypothetical protein, conserved 0.0024 0.0536 0.5
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0006 0.0062 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0062 0.5
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0046 0.1094 0.7399
Echinococcus granulosus lamin 0.0026 0.0581 0.495
Mycobacterium ulcerans beta-ketoacyl synthase-like protein 0.0383 1 0.5
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0046 0.1094 1
Trichomonas vaginalis chromodomain-helicase-DNA-binding protein, putative 0.0006 0.0062 0.5
Loa Loa (eye worm) hypothetical protein 0.0012 0.0212 0.0911
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0062 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0062 0.5
Schistosoma mansoni mixed-lineage leukemia protein mll 0.006 0.1479 1
Schistosoma mansoni intermediate filament proteins 0.0026 0.0581 0.3931
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0006 0.0062 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0062 0.5
Loa Loa (eye worm) hypothetical protein 0.0026 0.0569 0.4583
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0006 0.0062 0.5
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0046 0.1094 1
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0062 0.5
Schistosoma mansoni cpg binding protein 0.0028 0.0641 0.4331
Echinococcus granulosus cpg binding protein 0.003 0.0683 0.5953
Mycobacterium tuberculosis 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) 0.0383 1 0.5
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0006 0.0062 0.5
Schistosoma mansoni hypothetical protein 0.0011 0.0181 0.1227
Echinococcus granulosus lamin dm0 0.0026 0.0581 0.495
Mycobacterium ulcerans 3-oxoacyl-ACP synthase 0.0383 1 0.5
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0046 0.1094 1
Trypanosoma cruzi PAB1-binding protein , putative 0.0024 0.0536 0.5
Echinococcus multilocularis cpg binding protein 0.003 0.0683 0.5953
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0046 0.1094 1
Echinococcus multilocularis histone lysine N methyltransferase MLL3 0.0009 0.0124 0.0449
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0046 0.1094 1
Echinococcus multilocularis cytoplasmic intermediate filament protein 0.0013 0.0225 0.1443
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0006 0.0062 0.5
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0006 0.0062 0.5
Loa Loa (eye worm) cytoplasmic intermediate filament protein 0.0014 0.0262 0.1417
Entamoeba histolytica fatty acid elongase, putative 0.005 0.1205 0.5
Echinococcus multilocularis lamin 0.0026 0.0581 0.495
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0046 0.1094 1
Loa Loa (eye worm) CXXC zinc finger family protein 0.0028 0.0641 0.5323
Schistosoma mansoni cpg binding protein 0.003 0.0683 0.4619
Loa Loa (eye worm) hypothetical protein 0.0026 0.0581 0.4713
Toxoplasma gondii histone lysine methyltransferase SET1 0.0054 0.131 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0046 0.1094 0.7399
Echinococcus granulosus intermediate filament protein 0.0026 0.0581 0.495
Echinococcus multilocularis lamin dm0 0.0026 0.0581 0.495
Echinococcus granulosus Ataxin 2 N terminaldomain containing protein 0.0011 0.0181 0.1013
Loa Loa (eye worm) hypothetical protein 0.0013 0.0225 0.1041
Schistosoma mansoni lamin 0.0026 0.0581 0.3931
Schistosoma mansoni lamin 0.0026 0.0581 0.3931
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0046 0.1094 0.7399
Mycobacterium ulcerans 3-oxoacyl-ACP synthase 0.0383 1 0.5
Plasmodium falciparum beta-ketoacyl-ACP synthase III 0.0383 1 1
Brugia malayi cytoplasmic intermediate filament protein 0.0014 0.0262 0.1443
Plasmodium vivax beta-ketoacyl-acyl carrier protein synthase III precursor, putative 0.0383 1 1

Activities

Activity type Activity value Assay description Source Reference
Ki (binding) = 974.95 fmol Inhibition of N-terminal His-tagged Escherichia coli FabH expressed in Escherichia coli BL21 (DE3) using [3H]acetyl-coA after 25 mins by liquid scintillation counting ChEMBL. 21741250
MIC (functional) > 100 ug ml-1 Antibacterial activity against Escherichia coli ATCC35218 after 24 hrs by MTT assay ChEMBL. 21741250

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.